{
    "title": "Aclaris shares plummet on terminating development of rheumatoid arthritis drug",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12743177/Aclaris-Therapeutics-stop-development-rheumatoid-arthritis-drug.html",
    "date": "2023-11-13",
    "keywords": [
        "drug",
        "trial",
        "midstage",
        "arthritis",
        "zunsemetinib",
        "response",
        "milligram",
        "company",
        "monday",
        "development",
        "treatment",
        "bell",
        "methotrexate",
        "improvement",
        "rate",
        "reduction",
        "tender",
        "joint",
        "count",
        "pain",
        "differentiation",
        "placebo",
        "efficacy",
        "enrollment",
        "developer",
        "ati1777",
        "atopic",
        "dermatitis",
        "reporting",
        "roy",
        "bengaluru",
        "editing",
        "maju",
        "samuel"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}